nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—ovarian cancer—uterine cancer	0.43	1	CtDrD
Docetaxel—CYP1B1—Progesterone—uterine cancer	0.0398	0.119	CbGbCtD
Docetaxel—ABCC10—Etoposide—uterine cancer	0.0327	0.0977	CbGbCtD
Docetaxel—ABCC1—Progesterone—uterine cancer	0.0283	0.0843	CbGbCtD
Docetaxel—ABCC1—Dactinomycin—uterine cancer	0.0224	0.0669	CbGbCtD
Docetaxel—ABCC10—Doxorubicin—uterine cancer	0.0223	0.0667	CbGbCtD
Docetaxel—ABCC1—Epirubicin—uterine cancer	0.0162	0.0484	CbGbCtD
Docetaxel—ABCG2—Dactinomycin—uterine cancer	0.015	0.0447	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.014	0.0417	CbGbCtD
Docetaxel—CYP3A7—Progesterone—uterine cancer	0.014	0.0417	CbGbCtD
Docetaxel—ABCC1—Etoposide—uterine cancer	0.0126	0.0377	CbGbCtD
Docetaxel—CYP1B1—Doxorubicin—uterine cancer	0.0121	0.0362	CbGbCtD
Docetaxel—ABCC2—Carboplatin—uterine cancer	0.0111	0.0333	CbGbCtD
Docetaxel—CYP3A5—Progesterone—uterine cancer	0.0105	0.0313	CbGbCtD
Docetaxel—ABCG2—Carboplatin—uterine cancer	0.0101	0.0301	CbGbCtD
Docetaxel—ABCC2—Etoposide—uterine cancer	0.00936	0.0279	CbGbCtD
Docetaxel—ABCC1—Doxorubicin—uterine cancer	0.00862	0.0257	CbGbCtD
Docetaxel—ABCG2—Etoposide—uterine cancer	0.00846	0.0252	CbGbCtD
Docetaxel—ABCB1—Progesterone—uterine cancer	0.00682	0.0203	CbGbCtD
Docetaxel—ABCC2—Doxorubicin—uterine cancer	0.00638	0.019	CbGbCtD
Docetaxel—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.00617	0.0184	CbGbCtD
Docetaxel—ABCG2—Doxorubicin—uterine cancer	0.00577	0.0172	CbGbCtD
Docetaxel—ABCB1—Dactinomycin—uterine cancer	0.00541	0.0161	CbGbCtD
Docetaxel—CYP3A5—Etoposide—uterine cancer	0.00469	0.014	CbGbCtD
Docetaxel—CYP3A4—Progesterone—uterine cancer	0.00408	0.0122	CbGbCtD
Docetaxel—ABCB1—Etoposide—uterine cancer	0.00305	0.0091	CbGbCtD
Docetaxel—ABCB1—Doxorubicin—uterine cancer	0.00208	0.00621	CbGbCtD
Docetaxel—CYP3A4—Etoposide—uterine cancer	0.00183	0.00545	CbGbCtD
Docetaxel—KIF11—Teniposide—Etoposide—uterine cancer	0.00148	1	CbGdCrCtD
Docetaxel—KIF11—endometrium—uterine cancer	0.00132	0.025	CbGeAlD
Docetaxel—TUBB4B—oviduct—uterine cancer	0.00128	0.0242	CbGeAlD
Docetaxel—KIF11—mammalian vulva—uterine cancer	0.00128	0.0241	CbGeAlD
Docetaxel—CYP3A4—Doxorubicin—uterine cancer	0.00125	0.00372	CbGbCtD
Docetaxel—KIF11—female reproductive system—uterine cancer	0.00109	0.0207	CbGeAlD
Docetaxel—KIF11—female gonad—uterine cancer	0.000996	0.0188	CbGeAlD
Docetaxel—KIF11—vagina—uterine cancer	0.00099	0.0187	CbGeAlD
Docetaxel—Paclitaxel—CYP19A1—uterine cancer	0.00089	1	CrCbGaD
Docetaxel—MAP2—myometrium—uterine cancer	0.000681	0.0129	CbGeAlD
Docetaxel—MAP4—uterine cervix—uterine cancer	0.000673	0.0127	CbGeAlD
Docetaxel—MAP4—decidua—uterine cancer	0.000642	0.0121	CbGeAlD
Docetaxel—KIF11—lymph node—uterine cancer	0.00064	0.0121	CbGeAlD
Docetaxel—MAP4—renal system—uterine cancer	0.00063	0.0119	CbGeAlD
Docetaxel—TUBB1—decidua—uterine cancer	0.000627	0.0118	CbGeAlD
Docetaxel—BCL2—epithelium—uterine cancer	0.000617	0.0117	CbGeAlD
Docetaxel—EGFR—uterine cervix—uterine cancer	0.000605	0.0114	CbGeAlD
Docetaxel—BCL2—smooth muscle tissue—uterine cancer	0.000595	0.0112	CbGeAlD
Docetaxel—BCL2—renal system—uterine cancer	0.000573	0.0108	CbGeAlD
Docetaxel—MAP4—uterus—uterine cancer	0.000561	0.0106	CbGeAlD
Docetaxel—BCL2—endometrium—uterine cancer	0.000554	0.0105	CbGeAlD
Docetaxel—MAP2—uterine cervix—uterine cancer	0.00053	0.01	CbGeAlD
Docetaxel—EGFR—mammalian vulva—uterine cancer	0.000529	0.00999	CbGeAlD
Docetaxel—BCL2—uterus—uterine cancer	0.00051	0.00963	CbGeAlD
Docetaxel—TUBB2B—myometrium—uterine cancer	0.000509	0.00961	CbGeAlD
Docetaxel—MAP2—decidua—uterine cancer	0.000505	0.00954	CbGeAlD
Docetaxel—MAP4—female reproductive system—uterine cancer	0.000505	0.00953	CbGeAlD
Docetaxel—EGFR—uterus—uterine cancer	0.000504	0.00952	CbGeAlD
Docetaxel—TUBB—myometrium—uterine cancer	0.000482	0.00909	CbGeAlD
Docetaxel—MAP2—endometrium—uterine cancer	0.00048	0.00906	CbGeAlD
Docetaxel—TUBB2A—myometrium—uterine cancer	0.000479	0.00905	CbGeAlD
Docetaxel—TUBB6—myometrium—uterine cancer	0.000473	0.00892	CbGeAlD
Docetaxel—MAP2—mammalian vulva—uterine cancer	0.000464	0.00876	CbGeAlD
Docetaxel—MAP4—female gonad—uterine cancer	0.000459	0.00867	CbGeAlD
Docetaxel—BCL2—female reproductive system—uterine cancer	0.000459	0.00866	CbGeAlD
Docetaxel—MAP4—vagina—uterine cancer	0.000456	0.00862	CbGeAlD
Docetaxel—SLC22A7—renal system—uterine cancer	0.000429	0.0081	CbGeAlD
Docetaxel—BCL2—female gonad—uterine cancer	0.000417	0.00788	CbGeAlD
Docetaxel—ABCC10—myometrium—uterine cancer	0.000414	0.00781	CbGeAlD
Docetaxel—EGFR—female gonad—uterine cancer	0.000412	0.00779	CbGeAlD
Docetaxel—TUBB4B—myometrium—uterine cancer	0.000411	0.00776	CbGeAlD
Docetaxel—TUBB4A—uterine cervix—uterine cancer	0.00041	0.00774	CbGeAlD
Docetaxel—SLCO1B3—vagina—uterine cancer	0.000399	0.00754	CbGeAlD
Docetaxel—MAP2—female reproductive system—uterine cancer	0.000397	0.0075	CbGeAlD
Docetaxel—TUBB2B—uterine cervix—uterine cancer	0.000396	0.00748	CbGeAlD
Docetaxel—TUBB4A—renal system—uterine cancer	0.000383	0.00724	CbGeAlD
Docetaxel—MAPT—lymph node—uterine cancer	0.000375	0.00709	CbGeAlD
Docetaxel—TUBB—uterine cervix—uterine cancer	0.000375	0.00708	CbGeAlD
Docetaxel—TUBB2A—uterine cervix—uterine cancer	0.000373	0.00704	CbGeAlD
Docetaxel—TUBB6—epithelium—uterine cancer	0.000371	0.007	CbGeAlD
Docetaxel—TUBB2B—renal system—uterine cancer	0.000371	0.007	CbGeAlD
Docetaxel—TUBB6—uterine cervix—uterine cancer	0.000368	0.00694	CbGeAlD
Docetaxel—TUBB—smooth muscle tissue—uterine cancer	0.000364	0.00688	CbGeAlD
Docetaxel—TUBB2A—smooth muscle tissue—uterine cancer	0.000362	0.00684	CbGeAlD
Docetaxel—MAP2—female gonad—uterine cancer	0.000362	0.00683	CbGeAlD
Docetaxel—MAP2—vagina—uterine cancer	0.000359	0.00678	CbGeAlD
Docetaxel—TUBB2B—endometrium—uterine cancer	0.000358	0.00676	CbGeAlD
Docetaxel—TUBB6—smooth muscle tissue—uterine cancer	0.000357	0.00675	CbGeAlD
Docetaxel—TUBB—decidua—uterine cancer	0.000357	0.00674	CbGeAlD
Docetaxel—TUBB2A—decidua—uterine cancer	0.000355	0.00671	CbGeAlD
Docetaxel—TUBB6—decidua—uterine cancer	0.00035	0.00662	CbGeAlD
Docetaxel—TUBB2B—mammalian vulva—uterine cancer	0.000347	0.00654	CbGeAlD
Docetaxel—TUBB6—renal system—uterine cancer	0.000344	0.0065	CbGeAlD
Docetaxel—TUBB4A—uterus—uterine cancer	0.000342	0.00645	CbGeAlD
Docetaxel—TUBB—endometrium—uterine cancer	0.000339	0.0064	CbGeAlD
Docetaxel—TUBB2A—endometrium—uterine cancer	0.000337	0.00637	CbGeAlD
Docetaxel—TUBB6—endometrium—uterine cancer	0.000333	0.00628	CbGeAlD
Docetaxel—TUBB—mammalian vulva—uterine cancer	0.000328	0.00619	CbGeAlD
Docetaxel—TUBB2A—mammalian vulva—uterine cancer	0.000326	0.00616	CbGeAlD
Docetaxel—ABCC10—uterine cervix—uterine cancer	0.000322	0.00608	CbGeAlD
Docetaxel—TUBB6—mammalian vulva—uterine cancer	0.000322	0.00607	CbGeAlD
Docetaxel—TUBB4B—uterine cervix—uterine cancer	0.00032	0.00604	CbGeAlD
Docetaxel—TUBB—uterus—uterine cancer	0.000312	0.0059	CbGeAlD
Docetaxel—TUBB2A—uterus—uterine cancer	0.000311	0.00587	CbGeAlD
Docetaxel—TUBB4B—smooth muscle tissue—uterine cancer	0.000311	0.00587	CbGeAlD
Docetaxel—TUBB4A—female reproductive system—uterine cancer	0.000307	0.0058	CbGeAlD
Docetaxel—ABCC10—decidua—uterine cancer	0.000307	0.00579	CbGeAlD
Docetaxel—TUBB6—uterus—uterine cancer	0.000306	0.00579	CbGeAlD
Docetaxel—TUBB4B—decidua—uterine cancer	0.000305	0.00575	CbGeAlD
Docetaxel—ABCC10—renal system—uterine cancer	0.000301	0.00569	CbGeAlD
Docetaxel—TUBB4B—renal system—uterine cancer	0.000299	0.00565	CbGeAlD
Docetaxel—TUBB2B—female reproductive system—uterine cancer	0.000297	0.0056	CbGeAlD
Docetaxel—MAP4—lymph node—uterine cancer	0.000295	0.00557	CbGeAlD
Docetaxel—ABCC1—myometrium—uterine cancer	0.000293	0.00553	CbGeAlD
Docetaxel—ABCC10—endometrium—uterine cancer	0.000291	0.0055	CbGeAlD
Docetaxel—TUBB4B—endometrium—uterine cancer	0.000289	0.00546	CbGeAlD
Docetaxel—ABCC10—mammalian vulva—uterine cancer	0.000282	0.00532	CbGeAlD
Docetaxel—TUBB4B—mammalian vulva—uterine cancer	0.00028	0.00528	CbGeAlD
Docetaxel—TUBB4A—female gonad—uterine cancer	0.000279	0.00528	CbGeAlD
Docetaxel—TUBB2A—female reproductive system—uterine cancer	0.000279	0.00527	CbGeAlD
Docetaxel—TUBB6—female reproductive system—uterine cancer	0.000275	0.0052	CbGeAlD
Docetaxel—TUBB2B—female gonad—uterine cancer	0.00027	0.0051	CbGeAlD
Docetaxel—TUBB2B—vagina—uterine cancer	0.000268	0.00507	CbGeAlD
Docetaxel—ABCC10—uterus—uterine cancer	0.000268	0.00507	CbGeAlD
Docetaxel—BCL2—lymph node—uterine cancer	0.000268	0.00507	CbGeAlD
Docetaxel—TUBB4B—uterus—uterine cancer	0.000266	0.00503	CbGeAlD
Docetaxel—EGFR—lymph node—uterine cancer	0.000265	0.00501	CbGeAlD
Docetaxel—TUBB—female gonad—uterine cancer	0.000256	0.00482	CbGeAlD
Docetaxel—TUBB2A—female gonad—uterine cancer	0.000254	0.0048	CbGeAlD
Docetaxel—TUBB—vagina—uterine cancer	0.000254	0.0048	CbGeAlD
Docetaxel—TUBB2A—vagina—uterine cancer	0.000253	0.00477	CbGeAlD
Docetaxel—TUBB6—female gonad—uterine cancer	0.000251	0.00473	CbGeAlD
Docetaxel—TUBB6—vagina—uterine cancer	0.000249	0.0047	CbGeAlD
Docetaxel—CYP1B1—smooth muscle tissue—uterine cancer	0.000246	0.00465	CbGeAlD
Docetaxel—ABCG2—myometrium—uterine cancer	0.000242	0.00457	CbGeAlD
Docetaxel—ABCC2—renal system—uterine cancer	0.000242	0.00457	CbGeAlD
Docetaxel—ABCC10—female reproductive system—uterine cancer	0.000241	0.00455	CbGeAlD
Docetaxel—CYP1B1—decidua—uterine cancer	0.000241	0.00455	CbGeAlD
Docetaxel—TUBB4B—female reproductive system—uterine cancer	0.000239	0.00452	CbGeAlD
Docetaxel—CYP1B1—renal system—uterine cancer	0.000237	0.00447	CbGeAlD
Docetaxel—MAP2—lymph node—uterine cancer	0.000232	0.00439	CbGeAlD
Docetaxel—ABCC1—uterine cervix—uterine cancer	0.000228	0.0043	CbGeAlD
Docetaxel—ABCC10—female gonad—uterine cancer	0.000219	0.00414	CbGeAlD
Docetaxel—ABCC10—vagina—uterine cancer	0.000218	0.00412	CbGeAlD
Docetaxel—TUBB4B—female gonad—uterine cancer	0.000218	0.00411	CbGeAlD
Docetaxel—ABCC1—decidua—uterine cancer	0.000217	0.0041	CbGeAlD
Docetaxel—TUBB4B—vagina—uterine cancer	0.000217	0.00409	CbGeAlD
Docetaxel—CYP1B1—uterus—uterine cancer	0.000211	0.00398	CbGeAlD
Docetaxel—ABCC1—endometrium—uterine cancer	0.000206	0.00389	CbGeAlD
Docetaxel—ABCC1—mammalian vulva—uterine cancer	0.000199	0.00376	CbGeAlD
Docetaxel—ABCC2—female reproductive system—uterine cancer	0.000194	0.00366	CbGeAlD
Docetaxel—ABCC1—uterus—uterine cancer	0.00019	0.00358	CbGeAlD
Docetaxel—CYP1B1—female reproductive system—uterine cancer	0.00019	0.00358	CbGeAlD
Docetaxel—ABCG2—uterine cervix—uterine cancer	0.000189	0.00356	CbGeAlD
Docetaxel—ABCG2—decidua—uterine cancer	0.00018	0.00339	CbGeAlD
Docetaxel—TUBB4A—lymph node—uterine cancer	0.00018	0.00339	CbGeAlD
Docetaxel—CYP3A5—uterine cervix—uterine cancer	0.000175	0.0033	CbGeAlD
Docetaxel—TUBB2B—lymph node—uterine cancer	0.000174	0.00328	CbGeAlD
Docetaxel—CYP1B1—female gonad—uterine cancer	0.000173	0.00326	CbGeAlD
Docetaxel—ABCG2—endometrium—uterine cancer	0.000171	0.00322	CbGeAlD
Docetaxel—ABCG2—mammalian vulva—uterine cancer	0.000165	0.00311	CbGeAlD
Docetaxel—TUBB—lymph node—uterine cancer	0.000164	0.0031	CbGeAlD
Docetaxel—CYP3A5—renal system—uterine cancer	0.000164	0.00309	CbGeAlD
Docetaxel—TUBB2A—lymph node—uterine cancer	0.000163	0.00309	CbGeAlD
Docetaxel—TUBB6—lymph node—uterine cancer	0.000161	0.00304	CbGeAlD
Docetaxel—ABCG2—uterus—uterine cancer	0.000157	0.00297	CbGeAlD
Docetaxel—ABCC1—female gonad—uterine cancer	0.000155	0.00293	CbGeAlD
Docetaxel—ABCC1—vagina—uterine cancer	0.000154	0.00291	CbGeAlD
Docetaxel—ABCC10—lymph node—uterine cancer	0.000141	0.00266	CbGeAlD
Docetaxel—TUBB4B—lymph node—uterine cancer	0.00014	0.00265	CbGeAlD
Docetaxel—ABCG2—female gonad—uterine cancer	0.000129	0.00243	CbGeAlD
Docetaxel—ABCG2—vagina—uterine cancer	0.000128	0.00241	CbGeAlD
Docetaxel—CYP3A4—renal system—uterine cancer	0.000123	0.00232	CbGeAlD
Docetaxel—ABCB1—myometrium—uterine cancer	0.000119	0.00226	CbGeAlD
Docetaxel—CYP3A5—female gonad—uterine cancer	0.000119	0.00225	CbGeAlD
Docetaxel—CYP3A5—vagina—uterine cancer	0.000119	0.00224	CbGeAlD
Docetaxel—ABCC2—lymph node—uterine cancer	0.000113	0.00214	CbGeAlD
Docetaxel—CYP1B1—lymph node—uterine cancer	0.000111	0.0021	CbGeAlD
Docetaxel—ABCC1—lymph node—uterine cancer	9.98e-05	0.00188	CbGeAlD
Docetaxel—CYP3A4—female reproductive system—uterine cancer	9.84e-05	0.00186	CbGeAlD
Docetaxel—ABCB1—epithelium—uterine cancer	9.38e-05	0.00177	CbGeAlD
Docetaxel—ABCB1—uterine cervix—uterine cancer	9.3e-05	0.00176	CbGeAlD
Docetaxel—ABCB1—decidua—uterine cancer	8.86e-05	0.00167	CbGeAlD
Docetaxel—ABCB1—renal system—uterine cancer	8.7e-05	0.00164	CbGeAlD
Docetaxel—ABCB1—endometrium—uterine cancer	8.41e-05	0.00159	CbGeAlD
Docetaxel—ABCG2—lymph node—uterine cancer	8.26e-05	0.00156	CbGeAlD
Docetaxel—ABCB1—mammalian vulva—uterine cancer	8.13e-05	0.00154	CbGeAlD
Docetaxel—ABCB1—uterus—uterine cancer	7.75e-05	0.00146	CbGeAlD
Docetaxel—ABCB1—female reproductive system—uterine cancer	6.96e-05	0.00132	CbGeAlD
Docetaxel—ABCB1—female gonad—uterine cancer	6.34e-05	0.0012	CbGeAlD
Docetaxel—ABCB1—vagina—uterine cancer	6.3e-05	0.00119	CbGeAlD
Docetaxel—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	5.22e-05	0.000456	CcSEcCtD
Docetaxel—Pain in extremity—Doxorubicin—uterine cancer	5.22e-05	0.000456	CcSEcCtD
Docetaxel—Liver function test abnormal—Epirubicin—uterine cancer	5.2e-05	0.000455	CcSEcCtD
Docetaxel—Nausea—Medroxyprogesterone Acetate—uterine cancer	5.2e-05	0.000454	CcSEcCtD
Docetaxel—Dry skin—Epirubicin—uterine cancer	5.17e-05	0.000452	CcSEcCtD
Docetaxel—Chest pain—Etoposide—uterine cancer	5.16e-05	0.000451	CcSEcCtD
Docetaxel—Orthostatic hypotension—Epirubicin—uterine cancer	5.15e-05	0.00045	CcSEcCtD
Docetaxel—Abdominal pain upper—Epirubicin—uterine cancer	5.15e-05	0.00045	CcSEcCtD
Docetaxel—Migraine—Doxorubicin—uterine cancer	5.13e-05	0.000449	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	5.12e-05	0.000447	CcSEcCtD
Docetaxel—Breast disorder—Epirubicin—uterine cancer	5.09e-05	0.000445	CcSEcCtD
Docetaxel—Aspartate aminotransferase increased—Epirubicin—uterine cancer	5.08e-05	0.000444	CcSEcCtD
Docetaxel—Toxic epidermal necrolysis—Epirubicin—uterine cancer	5.08e-05	0.000444	CcSEcCtD
Docetaxel—Nasopharyngitis—Epirubicin—uterine cancer	5.04e-05	0.000441	CcSEcCtD
Docetaxel—Hypersensitivity—Dactinomycin—uterine cancer	5.03e-05	0.00044	CcSEcCtD
Docetaxel—Confusional state—Etoposide—uterine cancer	4.98e-05	0.000436	CcSEcCtD
Docetaxel—Alanine aminotransferase increased—Epirubicin—uterine cancer	4.97e-05	0.000434	CcSEcCtD
Docetaxel—Anaphylactic shock—Etoposide—uterine cancer	4.94e-05	0.000432	CcSEcCtD
Docetaxel—Infection—Etoposide—uterine cancer	4.91e-05	0.000429	CcSEcCtD
Docetaxel—Ataxia—Doxorubicin—uterine cancer	4.9e-05	0.000429	CcSEcCtD
Docetaxel—Asthenia—Dactinomycin—uterine cancer	4.9e-05	0.000428	CcSEcCtD
Docetaxel—Dysphagia—Epirubicin—uterine cancer	4.87e-05	0.000426	CcSEcCtD
Docetaxel—Dehydration—Doxorubicin—uterine cancer	4.85e-05	0.000424	CcSEcCtD
Docetaxel—Thrombocytopenia—Etoposide—uterine cancer	4.84e-05	0.000423	CcSEcCtD
Docetaxel—Tachycardia—Etoposide—uterine cancer	4.82e-05	0.000422	CcSEcCtD
Docetaxel—Liver function test abnormal—Doxorubicin—uterine cancer	4.81e-05	0.000421	CcSEcCtD
Docetaxel—Skin disorder—Etoposide—uterine cancer	4.8e-05	0.00042	CcSEcCtD
Docetaxel—Dry skin—Doxorubicin—uterine cancer	4.78e-05	0.000418	CcSEcCtD
Docetaxel—Abdominal pain upper—Doxorubicin—uterine cancer	4.76e-05	0.000416	CcSEcCtD
Docetaxel—Orthostatic hypotension—Doxorubicin—uterine cancer	4.76e-05	0.000416	CcSEcCtD
Docetaxel—Angina pectoris—Epirubicin—uterine cancer	4.75e-05	0.000415	CcSEcCtD
Docetaxel—Breast disorder—Doxorubicin—uterine cancer	4.71e-05	0.000412	CcSEcCtD
Docetaxel—Anorexia—Etoposide—uterine cancer	4.71e-05	0.000412	CcSEcCtD
Docetaxel—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	4.7e-05	0.00041	CcSEcCtD
Docetaxel—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	4.7e-05	0.00041	CcSEcCtD
Docetaxel—Diarrhoea—Dactinomycin—uterine cancer	4.67e-05	0.000408	CcSEcCtD
Docetaxel—Nasopharyngitis—Doxorubicin—uterine cancer	4.66e-05	0.000408	CcSEcCtD
Docetaxel—Pancytopenia—Epirubicin—uterine cancer	4.63e-05	0.000404	CcSEcCtD
Docetaxel—Hypotension—Etoposide—uterine cancer	4.62e-05	0.000404	CcSEcCtD
Docetaxel—Alanine aminotransferase increased—Doxorubicin—uterine cancer	4.6e-05	0.000402	CcSEcCtD
Docetaxel—Neutropenia—Epirubicin—uterine cancer	4.56e-05	0.000398	CcSEcCtD
Docetaxel—Dysphagia—Doxorubicin—uterine cancer	4.51e-05	0.000394	CcSEcCtD
Docetaxel—Paraesthesia—Etoposide—uterine cancer	4.44e-05	0.000388	CcSEcCtD
Docetaxel—Weight increased—Epirubicin—uterine cancer	4.43e-05	0.000387	CcSEcCtD
Docetaxel—Weight decreased—Epirubicin—uterine cancer	4.41e-05	0.000385	CcSEcCtD
Docetaxel—Dyspnoea—Etoposide—uterine cancer	4.41e-05	0.000385	CcSEcCtD
Docetaxel—Somnolence—Etoposide—uterine cancer	4.39e-05	0.000384	CcSEcCtD
Docetaxel—Angina pectoris—Doxorubicin—uterine cancer	4.39e-05	0.000384	CcSEcCtD
Docetaxel—Pneumonia—Epirubicin—uterine cancer	4.37e-05	0.000382	CcSEcCtD
Docetaxel—Infestation NOS—Epirubicin—uterine cancer	4.34e-05	0.00038	CcSEcCtD
Docetaxel—Infestation—Epirubicin—uterine cancer	4.34e-05	0.00038	CcSEcCtD
Docetaxel—Vomiting—Dactinomycin—uterine cancer	4.34e-05	0.000379	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Epirubicin—uterine cancer	4.31e-05	0.000376	CcSEcCtD
Docetaxel—Rash—Dactinomycin—uterine cancer	4.31e-05	0.000376	CcSEcCtD
Docetaxel—Decreased appetite—Etoposide—uterine cancer	4.3e-05	0.000375	CcSEcCtD
Docetaxel—Pancytopenia—Doxorubicin—uterine cancer	4.28e-05	0.000374	CcSEcCtD
Docetaxel—Renal failure—Epirubicin—uterine cancer	4.27e-05	0.000373	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Etoposide—uterine cancer	4.27e-05	0.000373	CcSEcCtD
Docetaxel—Fatigue—Etoposide—uterine cancer	4.26e-05	0.000372	CcSEcCtD
Docetaxel—Neuropathy peripheral—Epirubicin—uterine cancer	4.26e-05	0.000372	CcSEcCtD
Docetaxel—Jaundice—Epirubicin—uterine cancer	4.23e-05	0.00037	CcSEcCtD
Docetaxel—Stomatitis—Epirubicin—uterine cancer	4.23e-05	0.00037	CcSEcCtD
Docetaxel—Constipation—Etoposide—uterine cancer	4.23e-05	0.000369	CcSEcCtD
Docetaxel—Pain—Etoposide—uterine cancer	4.23e-05	0.000369	CcSEcCtD
Docetaxel—Conjunctivitis—Epirubicin—uterine cancer	4.22e-05	0.000369	CcSEcCtD
Docetaxel—Neutropenia—Doxorubicin—uterine cancer	4.21e-05	0.000368	CcSEcCtD
Docetaxel—Hepatobiliary disease—Epirubicin—uterine cancer	4.11e-05	0.000359	CcSEcCtD
Docetaxel—Weight increased—Doxorubicin—uterine cancer	4.1e-05	0.000359	CcSEcCtD
Docetaxel—Epistaxis—Epirubicin—uterine cancer	4.1e-05	0.000358	CcSEcCtD
Docetaxel—Weight decreased—Doxorubicin—uterine cancer	4.08e-05	0.000356	CcSEcCtD
Docetaxel—ABCB1—lymph node—uterine cancer	4.07e-05	0.000769	CbGeAlD
Docetaxel—Feeling abnormal—Etoposide—uterine cancer	4.07e-05	0.000356	CcSEcCtD
Docetaxel—Nausea—Dactinomycin—uterine cancer	4.06e-05	0.000354	CcSEcCtD
Docetaxel—Agranulocytosis—Epirubicin—uterine cancer	4.05e-05	0.000354	CcSEcCtD
Docetaxel—Pneumonia—Doxorubicin—uterine cancer	4.04e-05	0.000353	CcSEcCtD
Docetaxel—Gastrointestinal pain—Etoposide—uterine cancer	4.04e-05	0.000353	CcSEcCtD
Docetaxel—Infestation—Doxorubicin—uterine cancer	4.02e-05	0.000351	CcSEcCtD
Docetaxel—Infestation NOS—Doxorubicin—uterine cancer	4.02e-05	0.000351	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	3.98e-05	0.000348	CcSEcCtD
Docetaxel—Renal failure—Doxorubicin—uterine cancer	3.95e-05	0.000345	CcSEcCtD
Docetaxel—Neuropathy peripheral—Doxorubicin—uterine cancer	3.94e-05	0.000344	CcSEcCtD
Docetaxel—Haemoglobin—Epirubicin—uterine cancer	3.92e-05	0.000343	CcSEcCtD
Docetaxel—Jaundice—Doxorubicin—uterine cancer	3.92e-05	0.000342	CcSEcCtD
Docetaxel—Stomatitis—Doxorubicin—uterine cancer	3.92e-05	0.000342	CcSEcCtD
Docetaxel—Rhinitis—Epirubicin—uterine cancer	3.91e-05	0.000342	CcSEcCtD
Docetaxel—Abdominal pain—Etoposide—uterine cancer	3.91e-05	0.000341	CcSEcCtD
Docetaxel—Body temperature increased—Etoposide—uterine cancer	3.91e-05	0.000341	CcSEcCtD
Docetaxel—Conjunctivitis—Doxorubicin—uterine cancer	3.91e-05	0.000341	CcSEcCtD
Docetaxel—Hepatitis—Epirubicin—uterine cancer	3.9e-05	0.000341	CcSEcCtD
Docetaxel—Haemorrhage—Epirubicin—uterine cancer	3.9e-05	0.000341	CcSEcCtD
Docetaxel—Hypoaesthesia—Epirubicin—uterine cancer	3.88e-05	0.000339	CcSEcCtD
Docetaxel—Pharyngitis—Epirubicin—uterine cancer	3.87e-05	0.000338	CcSEcCtD
Docetaxel—Urinary tract disorder—Epirubicin—uterine cancer	3.85e-05	0.000337	CcSEcCtD
Docetaxel—Oedema peripheral—Epirubicin—uterine cancer	3.84e-05	0.000336	CcSEcCtD
Docetaxel—Connective tissue disorder—Epirubicin—uterine cancer	3.83e-05	0.000335	CcSEcCtD
Docetaxel—Urethral disorder—Epirubicin—uterine cancer	3.82e-05	0.000334	CcSEcCtD
Docetaxel—Hepatobiliary disease—Doxorubicin—uterine cancer	3.8e-05	0.000332	CcSEcCtD
Docetaxel—Epistaxis—Doxorubicin—uterine cancer	3.79e-05	0.000331	CcSEcCtD
Docetaxel—Visual impairment—Epirubicin—uterine cancer	3.76e-05	0.000328	CcSEcCtD
Docetaxel—Agranulocytosis—Doxorubicin—uterine cancer	3.75e-05	0.000328	CcSEcCtD
Docetaxel—Erythema multiforme—Epirubicin—uterine cancer	3.69e-05	0.000322	CcSEcCtD
Docetaxel—Eye disorder—Epirubicin—uterine cancer	3.64e-05	0.000318	CcSEcCtD
Docetaxel—Hypersensitivity—Etoposide—uterine cancer	3.64e-05	0.000318	CcSEcCtD
Docetaxel—Haemoglobin—Doxorubicin—uterine cancer	3.63e-05	0.000317	CcSEcCtD
Docetaxel—Flushing—Epirubicin—uterine cancer	3.62e-05	0.000316	CcSEcCtD
Docetaxel—Cardiac disorder—Epirubicin—uterine cancer	3.62e-05	0.000316	CcSEcCtD
Docetaxel—Rhinitis—Doxorubicin—uterine cancer	3.62e-05	0.000316	CcSEcCtD
Docetaxel—Haemorrhage—Doxorubicin—uterine cancer	3.61e-05	0.000315	CcSEcCtD
Docetaxel—Hepatitis—Doxorubicin—uterine cancer	3.61e-05	0.000315	CcSEcCtD
Docetaxel—Hypoaesthesia—Doxorubicin—uterine cancer	3.59e-05	0.000314	CcSEcCtD
Docetaxel—Pharyngitis—Doxorubicin—uterine cancer	3.58e-05	0.000313	CcSEcCtD
Docetaxel—Urinary tract disorder—Doxorubicin—uterine cancer	3.56e-05	0.000311	CcSEcCtD
Docetaxel—Oedema peripheral—Doxorubicin—uterine cancer	3.55e-05	0.000311	CcSEcCtD
Docetaxel—Asthenia—Etoposide—uterine cancer	3.55e-05	0.00031	CcSEcCtD
Docetaxel—Connective tissue disorder—Doxorubicin—uterine cancer	3.55e-05	0.00031	CcSEcCtD
Docetaxel—Angiopathy—Epirubicin—uterine cancer	3.54e-05	0.000309	CcSEcCtD
Docetaxel—Urethral disorder—Doxorubicin—uterine cancer	3.54e-05	0.000309	CcSEcCtD
Docetaxel—Immune system disorder—Epirubicin—uterine cancer	3.52e-05	0.000308	CcSEcCtD
Docetaxel—Mediastinal disorder—Epirubicin—uterine cancer	3.51e-05	0.000307	CcSEcCtD
Docetaxel—Chills—Epirubicin—uterine cancer	3.5e-05	0.000306	CcSEcCtD
Docetaxel—Pruritus—Etoposide—uterine cancer	3.5e-05	0.000306	CcSEcCtD
Docetaxel—Arrhythmia—Epirubicin—uterine cancer	3.48e-05	0.000304	CcSEcCtD
Docetaxel—Visual impairment—Doxorubicin—uterine cancer	3.48e-05	0.000304	CcSEcCtD
Docetaxel—Alopecia—Epirubicin—uterine cancer	3.45e-05	0.000301	CcSEcCtD
Docetaxel—Mental disorder—Epirubicin—uterine cancer	3.42e-05	0.000299	CcSEcCtD
Docetaxel—Erythema multiforme—Doxorubicin—uterine cancer	3.41e-05	0.000298	CcSEcCtD
Docetaxel—Malnutrition—Epirubicin—uterine cancer	3.39e-05	0.000297	CcSEcCtD
Docetaxel—Erythema—Epirubicin—uterine cancer	3.39e-05	0.000297	CcSEcCtD
Docetaxel—Diarrhoea—Etoposide—uterine cancer	3.38e-05	0.000296	CcSEcCtD
Docetaxel—Eye disorder—Doxorubicin—uterine cancer	3.37e-05	0.000295	CcSEcCtD
Docetaxel—Flushing—Doxorubicin—uterine cancer	3.35e-05	0.000293	CcSEcCtD
Docetaxel—Cardiac disorder—Doxorubicin—uterine cancer	3.35e-05	0.000293	CcSEcCtD
Docetaxel—Dysgeusia—Epirubicin—uterine cancer	3.32e-05	0.000291	CcSEcCtD
Docetaxel—Back pain—Epirubicin—uterine cancer	3.28e-05	0.000287	CcSEcCtD
Docetaxel—Angiopathy—Doxorubicin—uterine cancer	3.27e-05	0.000286	CcSEcCtD
Docetaxel—Dizziness—Etoposide—uterine cancer	3.27e-05	0.000286	CcSEcCtD
Docetaxel—Muscle spasms—Epirubicin—uterine cancer	3.26e-05	0.000285	CcSEcCtD
Docetaxel—Immune system disorder—Doxorubicin—uterine cancer	3.26e-05	0.000285	CcSEcCtD
Docetaxel—Mediastinal disorder—Doxorubicin—uterine cancer	3.25e-05	0.000284	CcSEcCtD
Docetaxel—Chills—Doxorubicin—uterine cancer	3.24e-05	0.000283	CcSEcCtD
Docetaxel—Arrhythmia—Doxorubicin—uterine cancer	3.22e-05	0.000282	CcSEcCtD
Docetaxel—Alopecia—Doxorubicin—uterine cancer	3.19e-05	0.000279	CcSEcCtD
Docetaxel—Mental disorder—Doxorubicin—uterine cancer	3.16e-05	0.000276	CcSEcCtD
Docetaxel—Vomiting—Etoposide—uterine cancer	3.14e-05	0.000275	CcSEcCtD
Docetaxel—Malnutrition—Doxorubicin—uterine cancer	3.14e-05	0.000274	CcSEcCtD
Docetaxel—Erythema—Doxorubicin—uterine cancer	3.14e-05	0.000274	CcSEcCtD
Docetaxel—Anaemia—Epirubicin—uterine cancer	3.14e-05	0.000274	CcSEcCtD
Docetaxel—Rash—Etoposide—uterine cancer	3.12e-05	0.000272	CcSEcCtD
Docetaxel—Dermatitis—Etoposide—uterine cancer	3.11e-05	0.000272	CcSEcCtD
Docetaxel—Headache—Etoposide—uterine cancer	3.1e-05	0.000271	CcSEcCtD
Docetaxel—Dysgeusia—Doxorubicin—uterine cancer	3.08e-05	0.000269	CcSEcCtD
Docetaxel—Syncope—Epirubicin—uterine cancer	3.04e-05	0.000266	CcSEcCtD
Docetaxel—Leukopenia—Epirubicin—uterine cancer	3.04e-05	0.000266	CcSEcCtD
Docetaxel—Back pain—Doxorubicin—uterine cancer	3.04e-05	0.000266	CcSEcCtD
Docetaxel—Muscle spasms—Doxorubicin—uterine cancer	3.02e-05	0.000264	CcSEcCtD
Docetaxel—Palpitations—Epirubicin—uterine cancer	3e-05	0.000262	CcSEcCtD
Docetaxel—Loss of consciousness—Epirubicin—uterine cancer	2.98e-05	0.000261	CcSEcCtD
Docetaxel—Cough—Epirubicin—uterine cancer	2.96e-05	0.000259	CcSEcCtD
Docetaxel—Convulsion—Epirubicin—uterine cancer	2.94e-05	0.000257	CcSEcCtD
Docetaxel—Nausea—Etoposide—uterine cancer	2.94e-05	0.000257	CcSEcCtD
Docetaxel—Hypertension—Epirubicin—uterine cancer	2.93e-05	0.000256	CcSEcCtD
Docetaxel—Anaemia—Doxorubicin—uterine cancer	2.9e-05	0.000254	CcSEcCtD
Docetaxel—Myalgia—Epirubicin—uterine cancer	2.89e-05	0.000253	CcSEcCtD
Docetaxel—Arthralgia—Epirubicin—uterine cancer	2.89e-05	0.000253	CcSEcCtD
Docetaxel—Chest pain—Epirubicin—uterine cancer	2.89e-05	0.000253	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	2.87e-05	0.000251	CcSEcCtD
Docetaxel—Dry mouth—Epirubicin—uterine cancer	2.83e-05	0.000247	CcSEcCtD
Docetaxel—Syncope—Doxorubicin—uterine cancer	2.82e-05	0.000246	CcSEcCtD
Docetaxel—Leukopenia—Doxorubicin—uterine cancer	2.81e-05	0.000246	CcSEcCtD
Docetaxel—Confusional state—Epirubicin—uterine cancer	2.79e-05	0.000244	CcSEcCtD
Docetaxel—Palpitations—Doxorubicin—uterine cancer	2.78e-05	0.000243	CcSEcCtD
Docetaxel—Oedema—Epirubicin—uterine cancer	2.77e-05	0.000242	CcSEcCtD
Docetaxel—Anaphylactic shock—Epirubicin—uterine cancer	2.77e-05	0.000242	CcSEcCtD
Docetaxel—Loss of consciousness—Doxorubicin—uterine cancer	2.76e-05	0.000241	CcSEcCtD
Docetaxel—Infection—Epirubicin—uterine cancer	2.75e-05	0.000241	CcSEcCtD
Docetaxel—Cough—Doxorubicin—uterine cancer	2.74e-05	0.00024	CcSEcCtD
Docetaxel—Shock—Epirubicin—uterine cancer	2.73e-05	0.000238	CcSEcCtD
Docetaxel—Convulsion—Doxorubicin—uterine cancer	2.72e-05	0.000238	CcSEcCtD
Docetaxel—Nervous system disorder—Epirubicin—uterine cancer	2.72e-05	0.000237	CcSEcCtD
Docetaxel—Thrombocytopenia—Epirubicin—uterine cancer	2.71e-05	0.000237	CcSEcCtD
Docetaxel—Hypertension—Doxorubicin—uterine cancer	2.71e-05	0.000237	CcSEcCtD
Docetaxel—Tachycardia—Epirubicin—uterine cancer	2.7e-05	0.000236	CcSEcCtD
Docetaxel—Skin disorder—Epirubicin—uterine cancer	2.69e-05	0.000235	CcSEcCtD
Docetaxel—Arthralgia—Doxorubicin—uterine cancer	2.67e-05	0.000234	CcSEcCtD
Docetaxel—Chest pain—Doxorubicin—uterine cancer	2.67e-05	0.000234	CcSEcCtD
Docetaxel—Myalgia—Doxorubicin—uterine cancer	2.67e-05	0.000234	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	2.66e-05	0.000232	CcSEcCtD
Docetaxel—Anorexia—Epirubicin—uterine cancer	2.64e-05	0.000231	CcSEcCtD
Docetaxel—Dry mouth—Doxorubicin—uterine cancer	2.61e-05	0.000229	CcSEcCtD
Docetaxel—Hypotension—Epirubicin—uterine cancer	2.59e-05	0.000226	CcSEcCtD
Docetaxel—Confusional state—Doxorubicin—uterine cancer	2.58e-05	0.000226	CcSEcCtD
Docetaxel—Anaphylactic shock—Doxorubicin—uterine cancer	2.56e-05	0.000224	CcSEcCtD
Docetaxel—Oedema—Doxorubicin—uterine cancer	2.56e-05	0.000224	CcSEcCtD
Docetaxel—Infection—Doxorubicin—uterine cancer	2.55e-05	0.000223	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Epirubicin—uterine cancer	2.52e-05	0.000221	CcSEcCtD
Docetaxel—Shock—Doxorubicin—uterine cancer	2.52e-05	0.00022	CcSEcCtD
Docetaxel—Nervous system disorder—Doxorubicin—uterine cancer	2.51e-05	0.00022	CcSEcCtD
Docetaxel—Thrombocytopenia—Doxorubicin—uterine cancer	2.51e-05	0.000219	CcSEcCtD
Docetaxel—Insomnia—Epirubicin—uterine cancer	2.51e-05	0.000219	CcSEcCtD
Docetaxel—Tachycardia—Doxorubicin—uterine cancer	2.5e-05	0.000219	CcSEcCtD
Docetaxel—Skin disorder—Doxorubicin—uterine cancer	2.49e-05	0.000218	CcSEcCtD
Docetaxel—Paraesthesia—Epirubicin—uterine cancer	2.49e-05	0.000217	CcSEcCtD
Docetaxel—Dyspnoea—Epirubicin—uterine cancer	2.47e-05	0.000216	CcSEcCtD
Docetaxel—Somnolence—Epirubicin—uterine cancer	2.46e-05	0.000215	CcSEcCtD
Docetaxel—Anorexia—Doxorubicin—uterine cancer	2.44e-05	0.000214	CcSEcCtD
Docetaxel—Dyspepsia—Epirubicin—uterine cancer	2.44e-05	0.000213	CcSEcCtD
Docetaxel—Decreased appetite—Epirubicin—uterine cancer	2.41e-05	0.00021	CcSEcCtD
Docetaxel—Hypotension—Doxorubicin—uterine cancer	2.4e-05	0.000209	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Epirubicin—uterine cancer	2.39e-05	0.000209	CcSEcCtD
Docetaxel—Fatigue—Epirubicin—uterine cancer	2.39e-05	0.000209	CcSEcCtD
Docetaxel—Pain—Epirubicin—uterine cancer	2.37e-05	0.000207	CcSEcCtD
Docetaxel—Constipation—Epirubicin—uterine cancer	2.37e-05	0.000207	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Doxorubicin—uterine cancer	2.34e-05	0.000204	CcSEcCtD
Docetaxel—Insomnia—Doxorubicin—uterine cancer	2.32e-05	0.000203	CcSEcCtD
Docetaxel—Paraesthesia—Doxorubicin—uterine cancer	2.3e-05	0.000201	CcSEcCtD
Docetaxel—Dyspnoea—Doxorubicin—uterine cancer	2.29e-05	0.0002	CcSEcCtD
Docetaxel—Feeling abnormal—Epirubicin—uterine cancer	2.28e-05	0.0002	CcSEcCtD
Docetaxel—Somnolence—Doxorubicin—uterine cancer	2.28e-05	0.000199	CcSEcCtD
Docetaxel—Gastrointestinal pain—Epirubicin—uterine cancer	2.27e-05	0.000198	CcSEcCtD
Docetaxel—Dyspepsia—Doxorubicin—uterine cancer	2.26e-05	0.000197	CcSEcCtD
Docetaxel—Decreased appetite—Doxorubicin—uterine cancer	2.23e-05	0.000195	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Doxorubicin—uterine cancer	2.21e-05	0.000193	CcSEcCtD
Docetaxel—Fatigue—Doxorubicin—uterine cancer	2.21e-05	0.000193	CcSEcCtD
Docetaxel—Pain—Doxorubicin—uterine cancer	2.19e-05	0.000192	CcSEcCtD
Docetaxel—Constipation—Doxorubicin—uterine cancer	2.19e-05	0.000192	CcSEcCtD
Docetaxel—Body temperature increased—Epirubicin—uterine cancer	2.19e-05	0.000191	CcSEcCtD
Docetaxel—Abdominal pain—Epirubicin—uterine cancer	2.19e-05	0.000191	CcSEcCtD
Docetaxel—Feeling abnormal—Doxorubicin—uterine cancer	2.11e-05	0.000185	CcSEcCtD
Docetaxel—Gastrointestinal pain—Doxorubicin—uterine cancer	2.1e-05	0.000183	CcSEcCtD
Docetaxel—Hypersensitivity—Epirubicin—uterine cancer	2.04e-05	0.000178	CcSEcCtD
Docetaxel—Abdominal pain—Doxorubicin—uterine cancer	2.03e-05	0.000177	CcSEcCtD
Docetaxel—Body temperature increased—Doxorubicin—uterine cancer	2.03e-05	0.000177	CcSEcCtD
Docetaxel—Asthenia—Epirubicin—uterine cancer	1.99e-05	0.000174	CcSEcCtD
Docetaxel—Pruritus—Epirubicin—uterine cancer	1.96e-05	0.000171	CcSEcCtD
Docetaxel—Diarrhoea—Epirubicin—uterine cancer	1.9e-05	0.000166	CcSEcCtD
Docetaxel—Hypersensitivity—Doxorubicin—uterine cancer	1.89e-05	0.000165	CcSEcCtD
Docetaxel—Asthenia—Doxorubicin—uterine cancer	1.84e-05	0.000161	CcSEcCtD
Docetaxel—Dizziness—Epirubicin—uterine cancer	1.83e-05	0.00016	CcSEcCtD
Docetaxel—Pruritus—Doxorubicin—uterine cancer	1.81e-05	0.000159	CcSEcCtD
Docetaxel—Vomiting—Epirubicin—uterine cancer	1.76e-05	0.000154	CcSEcCtD
Docetaxel—Diarrhoea—Doxorubicin—uterine cancer	1.75e-05	0.000153	CcSEcCtD
Docetaxel—Rash—Epirubicin—uterine cancer	1.75e-05	0.000153	CcSEcCtD
Docetaxel—Dermatitis—Epirubicin—uterine cancer	1.75e-05	0.000153	CcSEcCtD
Docetaxel—Headache—Epirubicin—uterine cancer	1.74e-05	0.000152	CcSEcCtD
Docetaxel—Dizziness—Doxorubicin—uterine cancer	1.69e-05	0.000148	CcSEcCtD
Docetaxel—Nausea—Epirubicin—uterine cancer	1.65e-05	0.000144	CcSEcCtD
Docetaxel—Vomiting—Doxorubicin—uterine cancer	1.63e-05	0.000142	CcSEcCtD
Docetaxel—Rash—Doxorubicin—uterine cancer	1.62e-05	0.000141	CcSEcCtD
Docetaxel—Dermatitis—Doxorubicin—uterine cancer	1.61e-05	0.000141	CcSEcCtD
Docetaxel—Headache—Doxorubicin—uterine cancer	1.61e-05	0.00014	CcSEcCtD
Docetaxel—Nausea—Doxorubicin—uterine cancer	1.52e-05	0.000133	CcSEcCtD
Docetaxel—ABCG2—Metabolism—RRM2—uterine cancer	7.93e-06	0.000121	CbGpPWpGaD
Docetaxel—TUBB4B—Metabolism of proteins—CTNNB1—uterine cancer	7.9e-06	0.00012	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—HRAS—uterine cancer	7.9e-06	0.00012	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—AKT1—uterine cancer	7.87e-06	0.00012	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—AKT1—uterine cancer	7.87e-06	0.00012	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—AKT1—uterine cancer	7.87e-06	0.00012	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—RRM2—uterine cancer	7.86e-06	0.00012	CbGpPWpGaD
Docetaxel—EGFR—Disease—FBXW7—uterine cancer	7.81e-06	0.000119	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—AKT1—uterine cancer	7.8e-06	0.000119	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—AKR1C3—uterine cancer	7.79e-06	0.000119	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—PIK3CA—uterine cancer	7.76e-06	0.000118	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—AKT1—uterine cancer	7.73e-06	0.000118	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—DCN—uterine cancer	7.7e-06	0.000117	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—AKT1—uterine cancer	7.7e-06	0.000117	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.68e-06	0.000117	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—DCN—uterine cancer	7.63e-06	0.000116	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—uterine cancer	7.63e-06	0.000116	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	7.61e-06	0.000116	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—VEGFA—uterine cancer	7.61e-06	0.000116	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—AKR1C3—uterine cancer	7.53e-06	0.000115	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—NRAS—uterine cancer	7.51e-06	0.000115	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TP53—uterine cancer	7.51e-06	0.000114	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—AKT1—uterine cancer	7.44e-06	0.000113	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	7.41e-06	0.000113	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—AKT1—uterine cancer	7.29e-06	0.000111	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CDH1—uterine cancer	7.27e-06	0.000111	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CYP11A1—uterine cancer	7.26e-06	0.000111	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CYP11A1—uterine cancer	7.19e-06	0.00011	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—HRAS—uterine cancer	7.18e-06	0.000109	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—KRAS—uterine cancer	7.15e-06	0.000109	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CDH1—uterine cancer	7.08e-06	0.000108	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—ERBB2—uterine cancer	7.05e-06	0.000107	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	7.05e-06	0.000107	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—AKT1—uterine cancer	6.97e-06	0.000106	CbGpPWpGaD
Docetaxel—EGFR—Immune System—SOCS3—uterine cancer	6.92e-06	0.000106	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—TP53—uterine cancer	6.9e-06	0.000105	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—KRAS—uterine cancer	6.89e-06	0.000105	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—AKR1C3—uterine cancer	6.85e-06	0.000104	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—POLD1—uterine cancer	6.82e-06	0.000104	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—AKR1C3—uterine cancer	6.79e-06	0.000104	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	6.66e-06	0.000101	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—PIK3CA—uterine cancer	6.57e-06	0.0001	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AKR1B1—uterine cancer	6.56e-06	9.99e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—STAR—uterine cancer	6.56e-06	9.99e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CDKN2B—uterine cancer	6.49e-06	9.9e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	6.49e-06	9.89e-05	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—KRAS—uterine cancer	6.47e-06	9.86e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—MTHFR—uterine cancer	6.45e-06	9.83e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—AKR1C1—uterine cancer	6.38e-06	9.72e-05	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—AKT1—uterine cancer	6.34e-06	9.67e-05	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—PIK3CA—uterine cancer	6.33e-06	9.65e-05	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—TP53—uterine cancer	6.31e-06	9.61e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—ERBB2—uterine cancer	6.22e-06	9.49e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	6.19e-06	9.43e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—CTNNB1—uterine cancer	6.17e-06	9.4e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AKR1C3—uterine cancer	6.14e-06	9.35e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—ERBB2—uterine cancer	6.13e-06	9.35e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CDKN2B—uterine cancer	6.12e-06	9.33e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—HRAS—uterine cancer	6.07e-06	9.26e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—STK11—uterine cancer	6.07e-06	9.25e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CYP19A1—uterine cancer	6.07e-06	9.25e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PGR—uterine cancer	5.98e-06	9.12e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—ERBB2—uterine cancer	5.98e-06	9.11e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—SMAD3—uterine cancer	5.93e-06	9.04e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—STK11—uterine cancer	5.87e-06	8.94e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CYP19A1—uterine cancer	5.87e-06	8.94e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	5.86e-06	8.93e-05	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—HRAS—uterine cancer	5.86e-06	8.93e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—FGFR2—uterine cancer	5.77e-06	8.8e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CDKN1B—uterine cancer	5.76e-06	8.79e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—EP300—uterine cancer	5.73e-06	8.74e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—YWHAE—uterine cancer	5.71e-06	8.7e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.69e-06	8.68e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—RRM2—uterine cancer	5.68e-06	8.66e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.68e-06	8.66e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CDKN1B—uterine cancer	5.68e-06	8.66e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—FGFR2—uterine cancer	5.66e-06	8.62e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—SMAD3—uterine cancer	5.59e-06	8.52e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NDUFB11—uterine cancer	5.59e-06	8.52e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SRD5A2—uterine cancer	5.59e-06	8.52e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CDKN1B—uterine cancer	5.54e-06	8.44e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—DCN—uterine cancer	5.52e-06	8.41e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.51e-06	8.4e-05	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—HRAS—uterine cancer	5.5e-06	8.38e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FBXW7—uterine cancer	5.47e-06	8.34e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CTNNB1—uterine cancer	5.45e-06	8.3e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MTHFR—uterine cancer	5.44e-06	8.3e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.43e-06	8.28e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—VEGFA—uterine cancer	5.43e-06	8.27e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CTNNB1—uterine cancer	5.37e-06	8.18e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—AKT1—uterine cancer	5.36e-06	8.17e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—NRAS—uterine cancer	5.36e-06	8.17e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—STK11—uterine cancer	5.34e-06	8.14e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CYP19A1—uterine cancer	5.34e-06	8.14e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—FGFR2—uterine cancer	5.33e-06	8.12e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—PTEN—uterine cancer	5.31e-06	8.09e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—STK11—uterine cancer	5.29e-06	8.07e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CYP19A1—uterine cancer	5.29e-06	8.07e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.25e-06	8.01e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—PTEN—uterine cancer	5.23e-06	7.97e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CYP11A1—uterine cancer	5.2e-06	7.92e-05	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—AKT1—uterine cancer	5.17e-06	7.89e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—POLD1—uterine cancer	5.14e-06	7.84e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MTHFR—uterine cancer	5.13e-06	7.82e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—PTEN—uterine cancer	5.1e-06	7.77e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—EP300—uterine cancer	5.06e-06	7.72e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—EP300—uterine cancer	4.99e-06	7.6e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	4.98e-06	7.59e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—AKR1C3—uterine cancer	4.91e-06	7.48e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AKR1C1—uterine cancer	4.81e-06	7.34e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—STK11—uterine cancer	4.78e-06	7.29e-05	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—AKT1—uterine cancer	4.76e-06	7.26e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CCL2—uterine cancer	4.76e-06	7.25e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—NRAS—uterine cancer	4.74e-06	7.22e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—NRAS—uterine cancer	4.67e-06	7.11e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—KRAS—uterine cancer	4.62e-06	7.03e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	4.58e-06	6.98e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—MTHFR—uterine cancer	4.56e-06	6.95e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—NRAS—uterine cancer	4.55e-06	6.93e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SOCS3—uterine cancer	4.48e-06	6.82e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	4.43e-06	6.75e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—MTHFR—uterine cancer	4.41e-06	6.72e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CDH1—uterine cancer	4.3e-06	6.55e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—RRM2—uterine cancer	4.29e-06	6.54e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CDKN2B—uterine cancer	4.29e-06	6.53e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—DCN—uterine cancer	4.16e-06	6.35e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IGF1R—uterine cancer	4.16e-06	6.34e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—KRAS—uterine cancer	4.08e-06	6.21e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—STAR—uterine cancer	4.04e-06	6.16e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AKR1B1—uterine cancer	4.04e-06	6.16e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.02e-06	6.12e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—KRAS—uterine cancer	4.02e-06	6.12e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—MTHFR—uterine cancer	4.01e-06	6.11e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—MTHFR—uterine cancer	3.98e-06	6.06e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP11A1—uterine cancer	3.92e-06	5.98e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—HRAS—uterine cancer	3.92e-06	5.98e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—KRAS—uterine cancer	3.91e-06	5.97e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SMAD3—uterine cancer	3.91e-06	5.96e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.89e-06	5.92e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—STK11—uterine cancer	3.82e-06	5.83e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CYP19A1—uterine cancer	3.82e-06	5.83e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CXCL8—uterine cancer	3.76e-06	5.74e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—PIK3CA—uterine cancer	3.74e-06	5.71e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	3.74e-06	5.7e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FGFR2—uterine cancer	3.73e-06	5.69e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AKR1C3—uterine cancer	3.7e-06	5.65e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—PIK3CA—uterine cancer	3.69e-06	5.62e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—ERBB2—uterine cancer	3.63e-06	5.53e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—PIK3CA—uterine cancer	3.6e-06	5.48e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PTEN—uterine cancer	3.59e-06	5.47e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—ERBB2—uterine cancer	3.55e-06	5.41e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—HRAS—uterine cancer	3.46e-06	5.28e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—AKT1—uterine cancer	3.46e-06	5.28e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—EP300—uterine cancer	3.42e-06	5.21e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HRAS—uterine cancer	3.41e-06	5.2e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CDKN1B—uterine cancer	3.36e-06	5.12e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—ERBB2—uterine cancer	3.35e-06	5.1e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HRAS—uterine cancer	3.33e-06	5.07e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CDKN1B—uterine cancer	3.29e-06	5.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ESR1—uterine cancer	3.19e-06	4.87e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CTNNB1—uterine cancer	3.17e-06	4.83e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—POLD1—uterine cancer	3.17e-06	4.83e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CTNNB1—uterine cancer	3.11e-06	4.74e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CDKN1B—uterine cancer	3.1e-06	4.73e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PTEN—uterine cancer	3.09e-06	4.71e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—AKT1—uterine cancer	3.06e-06	4.66e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTEN—uterine cancer	3.03e-06	4.62e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—NRAS—uterine cancer	3.02e-06	4.6e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—AKT1—uterine cancer	3.01e-06	4.59e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AKR1C1—uterine cancer	2.96e-06	4.52e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—EP300—uterine cancer	2.95e-06	4.49e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—AKT1—uterine cancer	2.94e-06	4.48e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CTNNB1—uterine cancer	2.93e-06	4.46e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—EP300—uterine cancer	2.89e-06	4.4e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—STK11—uterine cancer	2.89e-06	4.4e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP19A1—uterine cancer	2.89e-06	4.4e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—MTHFR—uterine cancer	2.87e-06	4.38e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTEN—uterine cancer	2.85e-06	4.35e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCL2—uterine cancer	2.81e-06	4.29e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—NRAS—uterine cancer	2.76e-06	4.2e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—EP300—uterine cancer	2.72e-06	4.15e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NRAS—uterine cancer	2.7e-06	4.12e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—RRM2—uterine cancer	2.64e-06	4.03e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—KRAS—uterine cancer	2.6e-06	3.96e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—DCN—uterine cancer	2.57e-06	3.91e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—NRAS—uterine cancer	2.55e-06	3.88e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PTEN—uterine cancer	2.54e-06	3.87e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PIK3CA—uterine cancer	2.53e-06	3.86e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PTEN—uterine cancer	2.45e-06	3.74e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—EP300—uterine cancer	2.42e-06	3.69e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP11A1—uterine cancer	2.42e-06	3.68e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PIK3CA—uterine cancer	2.39e-06	3.64e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—KRAS—uterine cancer	2.37e-06	3.62e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ERBB2—uterine cancer	2.34e-06	3.57e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—EP300—uterine cancer	2.34e-06	3.57e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—KRAS—uterine cancer	2.33e-06	3.54e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AKR1C3—uterine cancer	2.28e-06	3.48e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PTEN—uterine cancer	2.23e-06	3.4e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CXCL8—uterine cancer	2.22e-06	3.39e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PTEN—uterine cancer	2.21e-06	3.37e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—HRAS—uterine cancer	2.21e-06	3.37e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—KRAS—uterine cancer	2.19e-06	3.34e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PIK3CA—uterine cancer	2.18e-06	3.32e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CDKN1B—uterine cancer	2.17e-06	3.31e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—MTHFR—uterine cancer	2.17e-06	3.31e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PIK3CA—uterine cancer	2.14e-06	3.26e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—EP300—uterine cancer	2.13e-06	3.24e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—EP300—uterine cancer	2.11e-06	3.22e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—AKT1—uterine cancer	2.07e-06	3.15e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CTNNB1—uterine cancer	2.05e-06	3.13e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HRAS—uterine cancer	2.02e-06	3.08e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PIK3CA—uterine cancer	2.01e-06	3.07e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PTEN—uterine cancer	2e-06	3.05e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HRAS—uterine cancer	1.98e-06	3.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—AKT1—uterine cancer	1.95e-06	2.97e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—EP300—uterine cancer	1.91e-06	2.91e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—HRAS—uterine cancer	1.86e-06	2.84e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—VEGFA—uterine cancer	1.81e-06	2.75e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CA—uterine cancer	1.79e-06	2.73e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NRAS—uterine cancer	1.78e-06	2.72e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—AKT1—uterine cancer	1.78e-06	2.72e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.78e-06	2.71e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—STK11—uterine cancer	1.78e-06	2.71e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—AKT1—uterine cancer	1.75e-06	2.66e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CA—uterine cancer	1.73e-06	2.64e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—AKT1—uterine cancer	1.64e-06	2.51e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTEN—uterine cancer	1.6e-06	2.44e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CA—uterine cancer	1.57e-06	2.4e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CA—uterine cancer	1.56e-06	2.38e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KRAS—uterine cancer	1.53e-06	2.34e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—EP300—uterine cancer	1.52e-06	2.32e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—AKT1—uterine cancer	1.46e-06	2.23e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—AKT1—uterine cancer	1.41e-06	2.15e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CA—uterine cancer	1.41e-06	2.15e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TP53—uterine cancer	1.36e-06	2.08e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—MTHFR—uterine cancer	1.34e-06	2.04e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HRAS—uterine cancer	1.3e-06	1.99e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—AKT1—uterine cancer	1.29e-06	1.96e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—AKT1—uterine cancer	1.27e-06	1.94e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTEN—uterine cancer	1.21e-06	1.84e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AKT1—uterine cancer	1.15e-06	1.76e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—EP300—uterine cancer	1.15e-06	1.75e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CA—uterine cancer	1.13e-06	1.72e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—AKT1—uterine cancer	9.21e-07	1.4e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CA—uterine cancer	8.51e-07	1.3e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTEN—uterine cancer	7.43e-07	1.13e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—EP300—uterine cancer	7.09e-07	1.08e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AKT1—uterine cancer	6.95e-07	1.06e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CA—uterine cancer	5.24e-07	7.99e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AKT1—uterine cancer	4.28e-07	6.53e-06	CbGpPWpGaD
